Diamedica Therapeutics Files SEC Report
Company Announcements

Diamedica Therapeutics Files SEC Report

Diamedica Therapeutics (DMAC) has released an update.

Diamedica Therapeutics Inc. has filed a current report with the SEC, indicating a significant event or update as of May 22, 2024. The company’s voting common shares are listed on The Nasdaq Stock Market under the ticker symbol DMAC. This report reflects the company’s continuous compliance with the regulatory requirements of the Securities Exchange Act of 1934.

For further insights into DMAC stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyBiotech Alert: Searches spiking for these stocks today
TheFlyDiaMedica Therapeutics initiated with a Buy at H.C. Wainwright
TheFlyDiaMedica Therapeutics reports Q2 EPS (13c), consensus (16)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App